论文部分内容阅读
目的探讨阿托伐他汀联合低分子肝素钠治疗肾病综合征患者的临床治疗效果。方法选取2014年7月至2015年7月在朝阳市中心医院接受治疗的190例肾病综合征患者作为研究对象,采用随机数字表法分为观察组和对照组,各95例。对照组患者在常规治疗的同时,应用低分子肝素钠,观察组患者在上述基础上应用阿托伐他汀。对比治疗前后血脂、肾功能指标变化,统计两组患者的治疗效果。结果治疗后,观察组血清白蛋白(Alb)、24 h尿蛋白定量(Pr)、血尿素氮(BUN)、血清总胆固醇(TC)、三酰甘油(TG)、高/低密度脂蛋白胆固醇(HDL-C/LDL-C)等相关指标以及总有效率均显著优于对照组,差异均有统计学意义(均P<0.05)。结论阿托伐他汀与低分子肝素钠联合治疗能够改善肾病综合征患者的血脂水平、纠正血液高凝状态,且能改善肾功能,总体治疗效果高,其可作为肾病综合征较为理想的药物治疗方案。
Objective To investigate the clinical effect of atorvastatin combined with low molecular weight heparin on nephrotic syndrome. Methods Totally 190 patients with nephrotic syndrome who were treated in Chaoyang Central Hospital from July 2014 to July 2015 were selected as study subjects and divided into observation group and control group with 95 cases in each group. Patients in the control group were treated with low molecular weight heparin at the same time as conventional treatment. Patients in the observation group were given atorvastatin on the above basis. Before and after treatment of blood lipids, renal function changes, statistical treatment of patients with two groups. Results After treatment, the levels of Alb, 24 h, BUN, TC, TG, high / low density lipoprotein cholesterol (HDL-C / LDL-C) and other related indicators and the total effective rate were significantly better than the control group, the difference was statistically significant (P <0.05). Conclusions Atorvastatin combined with LMWH can improve the level of blood lipids in patients with nephrotic syndrome, correct the hypercoagulable state of blood and improve the renal function. The overall treatment effect is high. It can be used as an ideal drug therapy for nephrotic syndrome Program.